Skip to content

Clinical trials

Completed Phase 1/2 Blood Coagulation Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Coagulation Disorders Phase: Phase 1/2 Status: Completed Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20151
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical2
Spark Therapeutics, Inc.2
Christian Fenger-Eriksen1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Coagulation Disorders6
Hematologic Diseases5
Hemorrhagic Disorders5
Blood Coagulation Disorders, Inherited4
Coagulation Protein Disorders4
Genetic Diseases, Inborn4
Hemophilia A4
Genetic Diseases, X-Linked2
Hemostatic Disorders2
Blood Platelet Disorders1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.